Literature DB >> 12130650

Role of amino acid residues in transmembrane segments IS6 and IIS6 of the Na+ channel alpha subunit in voltage-dependent gating and drug block.

Vladimir Yarov-Yarovoy1, Jancy C McPhee, Diane Idsvoog, Caroline Pate, Todd Scheuer, William A Catterall.   

Abstract

Alanine-scanning mutagenesis of transmembrane segments IS6 and IIS6 of the rat brain Na(v)1.2 channel alpha subunit identified mutations N418A in IS6 and L975A in IIS6 as causing strong positive shifts in the voltage dependence of activation. In contrast, mutations V424A in IS6 and L983A in IIS6 caused strong negative shifts. Most IS6 mutations opposed inactivation from closed states, but most IIS6 mutations favored such inactivation. Mutations L421C and L983A near the intracellular ends of IS6 and IIS6, respectively, exhibited significant sustained Na(+) currents at the end of 30-ms depolarizations, indicating a role for these residues in Na(+) channel fast inactivation. These residues, in combination with residues at the intracellular end of IVS6, are well situated to form an inactivation gate receptor. Mutation I409A in IS6 reduced the affinity of the local anesthetic etidocaine for the inactivated state by 6-fold, and mutations I409A and N418A reduced use-dependent block by etidocaine. No IS6 or IIS6 mutations studied affected inactivated-state affinity or use-dependent block by the neuroprotective drug sipatrigine (compound 619C89). These results suggest that the local anesthetic receptor site is formed primarily by residues in segments IIIS6 and IVS6 with the contribution of a single amino acid in segment IS6.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12130650     DOI: 10.1074/jbc.M206126200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  90 in total

1.  Veratridine block of rat skeletal muscle Nav1.4 sodium channels in the inner vestibule.

Authors:  Ging Kuo Wang; Sho-Ya Wang
Journal:  J Physiol       Date:  2003-03-07       Impact factor: 5.182

2.  Pharmacology and Toxicology of Nav1.5-Class 1 anti-arrhythmic drugs.

Authors:  Dan M Roden
Journal:  Card Electrophysiol Clin       Date:  2014-12-01

3.  In silico activation of KcsA K+ channel by lateral forces applied to the C-termini of inner helices.

Authors:  Denis B Tikhonov; Boris S Zhorov
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

Review 4.  Voltage-gated sodium channels at 60: structure, function and pathophysiology.

Authors:  William A Catterall
Journal:  J Physiol       Date:  2012-04-02       Impact factor: 5.182

5.  Molecular model of anticonvulsant drug binding to the voltage-gated sodium channel inner pore.

Authors:  Gregory M Lipkind; Harry A Fozzard
Journal:  Mol Pharmacol       Date:  2010-07-19       Impact factor: 4.436

Review 6.  Bacterial voltage-gated sodium channels (BacNa(V)s) from the soil, sea, and salt lakes enlighten molecular mechanisms of electrical signaling and pharmacology in the brain and heart.

Authors:  Jian Payandeh; Daniel L Minor
Journal:  J Mol Biol       Date:  2014-08-23       Impact factor: 5.469

7.  Accessibility of mid-segment domain IV S6 residues of the voltage-gated Na+ channel to methanethiosulfonate reagents.

Authors:  Akihiko Sunami; Arlene Tracey; Ian W Glaaser; Gregory M Lipkind; Dorothy A Hanck; Harry A Fozzard
Journal:  J Physiol       Date:  2004-10-07       Impact factor: 5.182

8.  Structural determinants of drugs acting on the Nav1.8 channel.

Authors:  Liam E Browne; Frank E Blaney; Shahnaz P Yusaf; Jeff J Clare; Dennis Wray
Journal:  J Biol Chem       Date:  2009-02-19       Impact factor: 5.157

9.  Investigating the putative glycine hinge in Shaker potassium channel.

Authors:  Shinghua Ding; Lindsey Ingleby; Christopher A Ahern; Richard Horn
Journal:  J Gen Physiol       Date:  2005-08-15       Impact factor: 4.086

Review 10.  Structure and function of voltage-gated sodium channels at atomic resolution.

Authors:  William A Catterall
Journal:  Exp Physiol       Date:  2013-10-04       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.